Investigation Overview
September 23, 2014 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) concerning potential breaches of fiduciary duties by certain directors and officers of Aegerion Pharmaceuticals was announced. The investigation by a law firm for current long term investors in Aegerion Pharmaceuticals, In...
You must register (for free) or login to view the entire investigation.